Enabling Better Care for Patients, Providers, Health Systems and Payors
Four out of five kidney failures come by surprise. Until now, identifying diabetic kidney disease patients most at risk has been a challenge. KidneyIntelX™ delivers critical and timely information to assess the risk of progressive kidney function decline in patients with type 2 diabetes – to optimize care and promote better outcomes.
For Providers
Enables proactive intervention to delay or prevent progressive kidney function decline in diabetic kidney disease patients
Learn More
For Payors
Drives an efficient and effective care path to improve patient outcomes while reducing healthcare costs
Learn More
For Patients
Delivers important information to help you and your doctor choose the care plan that's the best fit for you and your individual needs
Learn MoreFirst in Early Rapid Kidney Function Decline Prediction
KidneyIntelX is the only clinical diagnostic tool available that assesses the risk of progressive kidney function decline in CKD patients with type 2 diabetes.
AI-driven insights provide a personalized patient risk score, allowing physicians to improve monitoring and ongoing treatment.
Meet Our CKD
Advisory Board
Our Chronic Kidney Disease Advisory Board includes distinguished thought leaders and clinical advocates across the fields of nephrology, bioinformatics, and precision medicine.
Chirag R Parikh,
MD, PhD, Chair
Director, Division of Nephrology, Ronald Peterson Professor of Medicine, Johns Hopkins School of Medicine
View Bio
Order a Test Kit
Clinicians can order a KidneyIntelX test kit online by contacting customer service